BodyGuardian enables continuous or intermittent physiological monitoring and detection of abnormalities arising from a range of medical conditions before they lead to clinically significant concerns. It does not require surgical implantation of sensors and provides an alternative to in-hospital monitoring.

Mayo Clinic joins forces with theheart.org to provide a unique perspective on patient care, clinical trials, news and events in cardiology via video and podcasts.

TACT trial studies safety and efficacy of EDTA chelation therapy
A 68 percent increase in use led researchers to evaluate the efficacy of disodium EDTA chelation in the treatment CAD. While not conclusive, the results signal possible benefit for patients with diabetes and prior anterior MI.

Genetic research and high-precision microscopy may prevent hypertrophic cardiomyopathy
Researchers evaluate myosin and actin genes from children with hypertrophic cardiomyopathy to determine the molecular events that lead to the disease's symptoms. In nearly half of all cases, the genetic problems that occur are a result of spontaneous mutation.

20th Annual Echocardiographic Workshop on 2-D and Doppler Echocardiography at Vail
March 11-14, 2013, in Vail, Colo.
This program provides a comprehensive review of 2-D, Doppler and transesophageal echocardiography with emphasis on rapidly changing areas. Topics include diastology, ischemic heart disease, valvular heart disease, application of TEE in clinical practice and cardiomyopathy.

Echo Fiesta: An In-Depth Review of Adult Echocardiography for Sonographers and Physicians
March 21-24, 2013, in San Antonio
Topics include assessment of systolic and diastolic function, quantitative Doppler and stress echocardiography, plus new 3-D echocardiography and Doppler and 2-D strain imaging. Learn practical points regarding daily use of these techniques.

Cardiology in the Capital: Case-Based Clinical Decision Making
April 25-27, 2013, in Washington, D.C.
Review relevant information regarding heart failure; arrhythmias; and ischemic, structural, and vascular heart disease. Topics include diagnostic, clinical and interventional options for circulatory failure; interventional strategies for valvular heart disease; and pharmacological, nonpharmacological and anticoagulation strategies for atrial fibrillation.

See all Cardiovascular Diseases Continuous Professional Development courses

New Grand Rounds presentations are available online

• Mayo Clinic in Arizona
  866-629-6362 (toll-free)
• Cardiovascular and Thoracic Surgery in Arizona
  480-342-2270
• Mayo Clinic in Florida
  800-634-1417 (toll-free)
• Mayo Clinic in Minnesota
  800-533-1564 (toll-free)
• Cardiovascular Diseases in Minnesota
  800-471-1727 (toll-free)
• Cardiovascular Surgery in Minnesota
  866-827-8810 (toll-free)
• Other Consults
  800-533-1564 (toll-free)
• Online Referrals

• Physician Update Video Blog
• Clinical Trials at Mayo Clinic
• Mayo School of Continuous Professional Development